EFTR
Effector Therapeutics Inc
NASDAQ: EFTR · HEALTHCARE · BIOTECHNOLOGY
$0.00
+0.00% today
Updated 2026-04-30
Market cap
$940.00
P/E ratio
—
P/S ratio
69.65x
EPS (TTM)
$-12.57
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Effector Therapeutics Inc (EFTR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Operating cash flow | $-27.60M | $13.84M | $-24.89M | $-25.90M | $-29.55M |
| Capital expenditures | $4000.00 | $154000.00 | $42000.00 | $192000.00 | $97000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $646000.00 | $499000.00 | $8.66M | $5.33M | $4.59M |
| Free cash flow | $-27.60M | $13.68M | $-24.93M | $-26.09M | $-29.65M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | $34.49M | — | — |